Additional Effects of Sternocleidomastoid Release With SNAGS in the Management of Cervicogenic Headache

NCT ID: NCT06534606

Last Updated: 2024-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-10

Study Completion Date

2024-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cervicogenic headache is a common type of headache in adults which causes disability and difficulty in everyday activities. According to the latest International Headache Society model, cervicogenic headache (CGH) is a secondary headache having C1-C2 dysfunction. SNAGs are highly effective in the treatment approach for these patients. Sternocleidomastoid muscle receive overactive tension from forward neck posture, increasing muscular fatigue and tone of muscles. This tension in SCM causes referred pain in the head and neck region. SNAGs are very effective but musculoskeletal impairments especially the tightness of sternocleidomastoid muscle still persist and can exacerbate symptoms. Manual therapy targeted to the SCM muscle may be effective for reducing headache and neck pain intensity and increasing performance of deep cervical flexors. Findings of this study will aid the therapists in choosing which technique to use while treating the patients. This will save therapist's time and effort as they will not be using the less effective treatment protocol. Furthermore, patient's time and investment will be used in the right direction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervicogenic Headache

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a randomized controlled trial having two groups. One group will receive SNAGs and the second will receive Sternocleidomastoid Release along with SNAGS. Both groups will be recruited concurrently.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional physical therapy Group

Both Group A and Group B will receive this conventional physical therapy protocol for cervicogenic headache.

* Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
* TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

In addition to this, they will receive Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

• Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Group Type ACTIVE_COMPARATOR

Electrotherapy and physical agents

Intervention Type PROCEDURE

Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

Headache SNAGs

Intervention Type PROCEDURE

Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

• Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Conventional physical therapy with sternocleidomastoid release

Both Group A and Group B will receive this conventional physical therapy protocol for cervicogenic headache.

* Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.
* TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

Headache SNAGs: In addition to the conventional physical therapy protocol, they will receive Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

* Frequency: 3 times a week for 2 weeks. 6 sessions in total. Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.
* Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Group Type EXPERIMENTAL

Electrotherapy and physical agents

Intervention Type PROCEDURE

Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

Headache SNAGs

Intervention Type PROCEDURE

Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

• Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Sternocleidomastoid Release

Intervention Type PROCEDURE

Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrotherapy and physical agents

Moist heat therapy: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

• TENS application: Frequency: 15 minutes, 3 times per week (alternatively) for 2 weeks.

Intervention Type PROCEDURE

Headache SNAGs

Headache SNAGs (Sustained Natural Apophyseal Glides) 5 sets of 10 repetitions. Each repetition will be given with a 10 second hold.

• Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Intervention Type PROCEDURE

Sternocleidomastoid Release

Sternocleidomastoid Release: Group B will also receive Sternocleidomastoid release in addition with headache SNAGs. Release to the sternocleidomastoid muscle will be given once per session for 5-8 minutes.Frequency: 3 times a week for 2 weeks. 6 sessions in total.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age group: 18-45 years old
* Both males and females
* Unilateral headache with no shift of side
* C1-C2 Dysfunction
* Positive flexion rotation test (Rotation restriction is greater than 10 degrees)
* Headache at least once a month in the last 3 months
* Headache with at least 4 score in NPRS (Sign and Symptoms of Neck Involvement)
* Headache with restriction of ROM in the neck
* Headache precipitated by:

Sustained neck movements, and awkward head positioning. External Pressure over upper cervical or occipital region

Headache Characteristics:

* Moderate-severe, non-throbbing pain, usually starting in the neck.
* Episodes of varying duration, or: fluctuating, continuous pain

Exclusion Criteria

* Headache of non-cervical origin
* Diagnosed Cases of:Cervical spondylosis,Cervical radiculopathy/ nerve root involvement/ disc herniation,Cervical instability/ fracture,Vertebrobasilar insufficiency ,Cervical spine surgery,Cervical spondylolisthesis,Spinal infection or tumors,Osteoporosis,History of trauma,Rheumatoid Arthritis,Inflammatory Arthritis
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation University Islamabad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Foundation University College of Physical Therapy

Rawalpindi, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FUI/CTR/2024/17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.